Contraception News and Research

Latest Contraception News and Research

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

5 Nov 2014

Mylan announces U.S. launch of generic Loestrin 24 Fe

Mylan Inc. today announced the U.S. launch of its Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate, which is the generic version of Warner Chilcott's Loestrin 24 Fe.

5 Nov 2014

State exchanges gird for round two

Covered California hopes to enroll more than half a million new residents this year, bringing total participants to about 1.7 million.

17 Oct 2014

Research roundup: Malpractice reforms and doctors' practice; Medicaid expansion's effect

Defensive medicine is considered by many to be a major source of wasteful medical spending in the United States.

17 Oct 2014

New book offers advice on how to meet contraceptive needs of women with chronic medical problems

Women with chronic medical conditions can be at higher risk for complications during pregnancy and therefore require specialized preconception and contraceptive care and counseling. However, many medical providers are hesitant to prescribe contraception to these women due to concerns about the safety of various contraceptives with co-existing medical disorders.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

Hubris is the greatest danger in wealthy countries -; a sort of smug assumption that advanced technologies and emergency-preparedness plans guarantee that Ebola and other germs will not spread. It was hubris that left Toronto's top hospitals battling SARS in 2003, long after the virus was conquered in poorer Vietnam. It was hubris that led the World Health Assembly in 2013 to cut the WHO's outbreak-response budget in favor of more programs to treat cancer and heart disease.

14 Oct 2014

Coverage gaps still persist among some populations

The Star Tribune reports on how some American Indians -- even now that the health law is in place -- continue to struggle with costs and other challenges related to securing health insurance. Meanwhile, the St. Louis Post-Dispatch examines how state decisions to expand Medicaid impact residents' options.

10 Oct 2014

Democrats spotlight women's health issues

The issue is figuring prominently in races in Colorado and New Hampshire, where Democratic incumbents are highlighting their differences with Republican challengers.

6 Oct 2014

Obama, health law star in campaign ads

The Center for Public Integrity says there have been more than 300,000 Obama-related ads this election cycle. Elsewhere, abortion figures prominently in Senate races such as Colorado's where Democrats look to push their differences with the GOP.

5 Oct 2014

Health exchange's one-year mark: Looking forward, looking back

As of Oct. 1, the health law's online marketplaces have been up and running for a year. News outlets offer status reports on what appears to have gone well, what problems remain as the second open enrollment period approaches and how these factors are playing politically.

3 Oct 2014

Access to long-term contraception lowers teen pregnancy rates, study says

The study counseled young women on the benefits of using long-lasting contraceptives like intrauterine devices and hormonal implants.

3 Oct 2014

State highlights: Calif. health insurers and contraception coverage; Alaska sues Xerox over Medicaid payment systems

Health insurance policies in California will have to cover all federally approved contraceptives for women by 2016 without charging co-payments under legislation signed this week by Gov. Jerry Brown, countering trends in other states and the U.S. Supreme Court. The bill, SB1053 by Sen. Holly Mitchell, D-Los Angeles, expands state laws that required coverage for most birth-control drugs and devices approved by the U.S. Food and Drug Administration. The new law mandates coverage for all FDA-approved contraception, prohibits co-payments and includes managed-care Medi-Cal plans, which are not expressly covered by current laws (Egelko, 9/27).

30 Sep 2014

Viewpoints: Hospitals helped by Medicaid expansion; why GOP candidates back OTC contraceptives

Now the Department of Health and Human Services has issued a report showing that ... thanks to the Affordable Care Act, hospitals across the country will save $5.7 billion in uncompensated care costs in 2014.

29 Sep 2014

Chemotherapy, radiotherapy have no negative effect on unborn babies

Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in Madrid have shown.

29 Sep 2014

Texas Rep. Brady ready to brawl for ways & means top spot

Rep. Kevin Brady, R-Texas, announced he will seek the chairmanship of this powerful House panel. Rep. Paul Ryan, R-Wis., was expected to have a smooth path to that position.

27 Sep 2014

Viewpoints: Surgery surprise: Out-of-network doctors' bills; consequences of making Medicaid enrollees pay premiums

The New York Times' Elisabeth Rosenthal offered an important lesson in healthcare economics over the weekend that's a must-read for anyone about to undergo a major medical procedure.

24 Sep 2014

Research roundup: Home health nurses' workloads; readmissions at the VA; SHOP choices

In anticipation of next year's premium announcements and given some information already made public, concerns have surfaced about the potential for double-digit percent increases in nongroup and small-group health insurance premiums. This analysis shows that, although average annual increases in small-group premiums over the past 13 years averaged roughly 5.5 percent, double-digit average premium increases are common for states and large metropolitan areas.

22 Sep 2014

Many see health law coverage as affordable, survey finds

That's most true among low-income consumers who receive subsidies to help pay their premiums, according to the Commonwealth Fund survey.

18 Sep 2014

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.

15 Sep 2014

Contraception News and Research

Latest Contraception News and Research

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Mylan announces U.S. launch of generic Loestrin 24 Fe

State exchanges gird for round two

Research roundup: Malpractice reforms and doctors' practice; Medicaid expansion's effect

New book offers advice on how to meet contraceptive needs of women with chronic medical problems

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

Coverage gaps still persist among some populations

Democrats spotlight women's health issues

Obama, health law star in campaign ads

Health exchange's one-year mark: Looking forward, looking back

Access to long-term contraception lowers teen pregnancy rates, study says

State highlights: Calif. health insurers and contraception coverage; Alaska sues Xerox over Medicaid payment systems

Viewpoints: Hospitals helped by Medicaid expansion; why GOP candidates back OTC contraceptives

Chemotherapy, radiotherapy have no negative effect on unborn babies

Texas Rep. Brady ready to brawl for ways & means top spot

Viewpoints: Surgery surprise: Out-of-network doctors' bills; consequences of making Medicaid enrollees pay premiums

Research roundup: Home health nurses' workloads; readmissions at the VA; SHOP choices

Many see health law coverage as affordable, survey finds

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Contraception News and Research

Latest Contraception News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in